search

Qilu Pharmaceutical (Inner Mongolia) Passes U.S. FDA Inspection

ABOUT US

图片名称

Qilu Pharmaceutical (Inner Mongolia) Passes U.S. FDA Inspection


Release time:

2018-04-14

The USFDA has completed the GMP compliance inspection of Qilu Pharmaceutical (Inner Mongolia), a subsidiary of Qilu Pharma Group. The inspection commenced on April 9, 2018, and was completed on April 12, 2018. All quality systems were evaluated in the inspection, and the facility received a successful response with ZERO FDA 483 observations.The good inspection results speak to our commitment to high standards of quality and excellence.It is the first FDA inspection for Inner Mongolia facilities, which represents an important milestone for the company to enter the US market.

齐鲁制药有限公司
齐鲁制药有限公司
齐鲁制药有限公司

 

Tel: +86-531-83127705831277048312770683127711

Address: 8888 Lvyou Road, High-tech Zone, Jinan, 250104, China

Email:export@qilu-pharma.com


监督举报

亲爱的合作伙伴:

欢迎举报以下行为!

索贿、暗箱操纵招标、内定中标单位、员工或亲属参与公司业务往来牟取私利、偷工减料、以次充好、故意刁难供应商等行为。

举报电话:0531-83126898/55820713/83126871

举报邮箱:qljc@qilu-pharma.com

收信地址:山东省济南市历城区旅游路8888号

齐鲁制药集团审计监察部

采购平台技术专线